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Background: ADAM17 mediates shedding of CD163 and tumor necrosis factor- (TNF-) during inflammation.
Results: Similar substrate sequence motifs in proTNF- and CD163 are essential for ADAM17-mediated cleavage.
Conclusion: The structural basis for shedding of CD163 and TNF- is disclosed.
Significance:The data provide newmolecular information on the inflammatory response and explain evolution of a regulatory
mechanism for CD163 expression.
Thehaptoglobin-hemoglobin receptorCD163 andproTNF-
are transmembrane macrophage proteins subjected to cleavage
by the inflammation-responsive protease ADAM17. This leads
to release of soluble CD163 (sCD163) and bioactive TNF-.
Sequence comparison of the juxtamembrane region identified
similar palindromic sequences in human CD163 (1044Arg-Ser-
Ser-Arg) and proTNF- (78Arg-Ser-Ser-Ser-Arg). In proTNF-
theArg-Ser-Ser-Ser-Argsequence issituatednext tothepreviously
established ADAM17 cleavage site. Site-directed mutagenesis
revealed that the sequences harbor essential information for effi-
cientcleavageof the twoproteinsuponADAM17stimulation.This
was further evidenced by analysis of mouse CD163 that, like
CD163 in other non-primates, does not contain the palindromic
CD163 sequence in the juxtamembrane region. Mouse CD163
resisted endotoxin- and phorbol ester-induced shedding, and ex
vivo analysis of knock-in of the Arg-Ser-Ser-Arg sequence in
mouse CD163 revealed a receptor shedding comparable with
that of human CD163. In conclusion, we have identified an
essential substrate motif for ADAM17-mediated CD163 and
proTNF- cleavage in macrophages. In addition, the present
data indicate that CD163, by incorporation of this motif in late
evolution, underwent a modification that allows for an instant
down-regulation of surface CD163 expression and inhibition of
hemoglobin uptake. This regulatory modality seems to have
coincided with the evolution of an enhanced hemoglobin-pro-
tecting role of the haptoglobin-CD163 system in primates.
ADAM17,2 alias TNF--converting enzyme, belongs to the
“a disintegrin and metalloproteinase (ADAM)” family of trans-
membrane proteases. It has a multi-substrate specificity, and it
is involved in several cellular processes such as cytokine, hor-
mone, and growth factor release (1). ADAM17-dependent
shedding is also involved in regulated intramembrane proteol-
ysis releasing cytoplasmic mediators and in inhibition of extra-
cellular signaling and ligand uptake by a rapid down-regulation
of surface receptors. Because of themany different substrates of
ADAM17, the protein has a key role in both homeostatic and
pathologic processes (2). ADAM17 is widely known for its acti-
vation of macrophage TNF- by cleavage of membrane-bound
proTNF- (3, 4), and as a consequence, it is designated TNF--
converting cleavage enzyme. TNF- is one of the most potent
proinflammatory cytokines known, which indicates an indirect
proinflammatory role of ADAM17 in inflammatory macro-
phages (2, 5). proTNF-, which is a homotrimeric type II trans-
membrane protein (N terminus in the cytoplasmic tail), is
cleaved by ADAM17 between Ala76 and Val77 (76A2V) in the
juxtamembrane region (3, 4, 6).
In accordance with promotion of the proinflammatory
state in macrophages, ADAM17 was also recently shown to
cleave and thereby down-regulate the surface expression of
the hemoglobin scavenger receptor CD163 (7). This receptor is
suggested to serve an anti-inflammatory function by clearance
of the extracellular haptoglobin-hemoglobin complexes and
the heme oxygenase-mediated conversion of proinflammatory
heme to anti-inflammatory heme metabolites (8, 9). The
ADAM17-mediated cleavage leads to generation of soluble
CD163 (sCD163), a byproduct that is highly up-regulated in
plasma during infectious and inflammatory conditions (7, 10).
CD163 is a type I transmembrane protein with an opposite
orientation as compared with proTNF-. The ADAM17-de-
pendent cleavage of the CD163 ectodomain occurs in the jux-
tamembrane region in an as yet unidentified cleavage site and
results in shedding of the sCD163 ectodomain, consisting of
nine SRCR domains (11, 12).
In contrast to TNF-, which is almost absent in normal
plasma, sCD163 is present in a rather high concentration (1–4
mg/liter) (12). Upon proinflammatory stimulation the plasma
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level of both proteins is rapidly elevated. Thiswas recently dem-
onstrated in a human study of experimental endotoxemia
where a bolus injection of LPS caused a fast and simultaneous
increase of TNF- and sCD163 (7). Both proteins peaked after
1.5 h, but although TNF- was no longer detectable in circula-
tion after 3 h, the LPS-induced increase in sCD163 persisted for
more than 24 h. In line with this an elevated level of sCD163 is
reported in patients suffering from various infectious and
inflammatory diseases such as sepsis, tuberculosis, diabetes,
human immunodeficiency virus, rheumatoid arthritis, and
hemophagocytosis (13).
The physiological role, if any, of sCD163 is so far unknown,
but it has been speculated that release of sCD163 and subse-
quent formation of an sCD163-haptoglobin-hemoglobin
complex may suppress the heme iron supply to hemolytic
bacteria and trypanosomes (14, 15). Moreover sCD163 has
been suggested to inhibit activated T lymphocyte proliferation
and recently also to promote recognition and phagocytosis of
Staphylococcus aureus (16, 17).
CD163 is expressed in all mammalian species, and the
human protein displays more than 71% amino acid similarity
to its reported orthologs including chimpanzee, greenmonkey,
swine, dog, cow, rat, and mouse CD163. Despite the very high
amino acid similarity, themechanism of haptoglobin-mediated
hemoglobin scavenging differs substantially between mice (18)
andhumans (19). In humans, efficient uptake of hemoglobin via
the CD163 system requires preformation of the haptoglobin-
hemoglobin complex, whereas mouse CD163 efficiently medi-
ates uptake of hemoglobin independent of haptoglobin-hemo-
globin complex formation.
To define the molecular basis for ADAM17-mediated cleav-
age of CD163, we have now made a comparative mutagenesis
analysis of proTNF- andCD163 cleavage inmice and humans.
This led to identification of a common motif for ADAM17-
mediated cleavage of the two protein humans and the surpris-
ing finding that inflammation-driven down-regulation of
CD163 by ADAM17-mediated cleavage seems specific for pri-
mate species.
EXPERIMENTAL PROCEDURES
Materials—Rat monoclonal (mAb) anti-mouse CD163
(3E10B10) used earlier (20) was a kind gift fromCytoguide ApS
(Aarhus Denmark). Biotinylated E10B10 was prepared by incu-
bating antibody with Biotin-NHS (Sigma-Aldrich, Copenha-
gen,Denmark) in 40molar excess at pH8.5. Excess biotinwas
subsequently removed by dialysis against 1 PBS, pH 7.4, over-
night at 4 °C. Rabbit polyclonal (pAb) anti-mouse CD163 was
directed against recombinantmouse CD163 SRCR domain 1–9
(DakoDenmarkA/S,Glostrup,Denmark) (18). Phorbol 12-my-
ristate 13-acetate (PMA) and lipopolysaccharide (LPS, serotype
0111:B4) were from Sigma-Aldrich, and mouse macrophage
colony-stimulating factor (M-CSF) were from Life Technologies
(Life Technologies Europe BV, Naerum, Denmark). Human
CD163 (hCD163) cDNA (7) andmouseCD163 (mCD163) cDNA
(18) were used earlier. cDNA encoding human proTNF- and
the proTNF- 78RS/AAmutant were synthesized by GenScript
(GenScript USA Inc., Piscataway, NJ) using GenBankTM acces-
sion number M10988.1 as template.
Cell Culture and Knockdown of ADAM17—Transfected
human embryonic kidney cells expressing either mCD163 or
hCD163 or variants thereof were established as described ear-
lier using the FlpIn system (Life Technologies, Taastrup, Den-
mark) (7). Knockdown of ADAM17 and subsequent semiquan-
titative RT-PCR analysis were done as described previously (7).
Murine bone marrow-derived macrophages (MBDMs) were
prepared by harvesting femurs and tibias from 8-week-old
C57BL/6NTac mice, and bone marrow was collected using the
method described in Ref. 21. Freshly collected bone marrow
cells were resuspended at 6  105 cells/ml in RPMI 1640 sup-
plemented with 10% FCS, 2 mM L-glutamine, and 25 ng/ml
M-CSF. Cells were cultured for 7 days and subsequently used as
described.
Cellular shedding of CD163was induced by 1 h of incubation
at 37 °C in PBS, pH 7.4, with or without 100 ng/ml PMA or,
where indicated, with a gradient of 100 to 105 ng/ml PMA.
MBDMs were incubated with 25 ng/ml LPS or 100 ng/ml PMA
in complete growth medium for 4 h at 37 °C. Where specified,
cells were preincubated with 250 nM TIMP3 inhibitor for 30
min at 37 °C (Sigma-Aldrich).
ELISA, Western Blotting, and Image Cytometry—TNF- was
measured by a commercial ELISA kit (mouse TNF- Instant
ELISA, eBioscience, Frankfurt, Germany). Mouse sCD163 was
measured by a sandwich ELISA assay using rabbit pAb anti-
mouse CD163 as capture antibody and biotinylated E10B10 as
detection antibody. In short, capture antibody was diluted to 2
g/ml in PBS, pH 7.4, and incubated overnight at 4 °C inmicro-
titer plates (Nunc MaxiSorp, Nunc A/S, Roskilde, Denmark).
Wells were blocked in 25 g/liter casein for 2 h at room temper-
ature and washed with PBST (1 PBS, pH 7.4, 0.5 mM NaCl,
0,1% Tween 20). The samples were diluted in 25 g/liter casein
and incubated in plates for 2 h at room temperature. The con-
centration of detection antibody was 1 g/ml. Antibody-anti-
gen complexes were visualized by horseradish peroxidase
(HRP)-conjugated streptavidin (Sigma-Aldrich) and a ready-
to-use solution of 3,3, 5,5-tetramethylbenzidine (Life Tech-
nologies). Enzyme reaction was quenched with 1 MH3PO4, and
absorbance was read at 450 nm in a microplate reader (Versa-
Max microplate reader, Molecular Devices Ltd., Hampshire,
UK). Mouse CD163 SRCR domain 1–9 was used as a calibrator
(protein standard) and was expressed and purified as described
previously (18). Human sCD163 was measured by a previously
established ELISA assay (22). Western blotting of sCD163 was
carried out using rabbit pAb anti-mouse CD163 and a second-
ary HRP-conjugated goat anti-rabbit IgG antibody (Sigma-Al-
drich). Immunoreactive bands were visualized on a FUJI
FLA3000 Gel Doc (Fujifilm Europe GmbH, Düsseldorf, Ger-
many) using an ECL substrate (Pierce) and a 240-s exposure
time. Intensities of immunoreactive bands were quantified
using the MultiGauge software (Fujifilm Europe GmbH). Cells
for image cytometry were prepared as described previously (23)
using ATTO488-conjugated rabbit pAb anti-mouse CD163
antibody. Cells were analyzed on a Nucleoview NC-3000 Flexi-
Cyte image cytometer (Chemometec A/S). Image cytometry
data were analyzed by FCS Express version 4.0 (De Novo Soft-
ware, Los Angeles, CA).
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Generation of CD163 Mutants and Chimeras—The human
CD163 mutants (hCD1631044RS/AA and hCD1631046SR/AA),
the mouse CD163 mutant (mCD163 RSSR) and the jux-
tamembrane chimeras (hCD163mjux, mCD163hjux) were
prepared using the Site-directed, Ligase-Independent
Mutagenesis (SLIM)method (24). ThemouseCD163 chimeras
(mCD163chim1–4) were constructed using an overlap exten-
sion PCR method (25). Templates for the PCR reactions con-
sisted of the pcDNA5/FRT plasmid containing either human
CD163 cDNA or mouse CD163 cDNA. Primers for hCD163
RS/AA were: FS, 5-TCCTTTATTGCAGTCGGG, RS, 5-ACC-
TGTTGTGGCTTTTTG, FT, 5-CGCTCAGCCGCACAGT-
CATCCTTTATTGCAGTCGGG, RT, 5-TGACTGTGCGG-
CTGAGCGACCTGTTGTGCCTTTTTG. Primers for hCD-
163 SR/AA were: FS, 5-TCCTTTATTGCAGTCGGG, RS, 5-
ACCTGTTGTGGCTTTTTG, FT, 5-GCCGCATCCCGTCA-
GTCATCCTTTATTGCAGTCGGG, RT, 5-TGACTGACG-
GGATGCGGCACCTGTTGTGGCTTTTTG. Primers for
mCD163 RSSR were: FS, 5-CACCCCACCCTCACGGCA, RS,
5-ACCTGTGCCATGATGTGA, FT, 5-CGCTCATCCCGT-
CACCCCACCCTCACGGCA, RT, 5-ACGGGATGAGCGA-
CCTGTGCCATGATGTGA. Primers for hCD163mjux were:
FS, 5-TTTATTGCAGTCGGGATC, RS, 5-TGTGCAATTC-
ACTGCAGC, FT, 5-GAATCACACATGGCACAGGTCAC-
CCCACCTTTATTGCAGTCGGGATC, RT, 5-TGTGCCAT-
GATGTGATTCTGAAGTCATTTTTGGTGTGCAATTCA-
CTGCAGC. Primers for mCD163hjux were: FS, 5-CTCACG-
GCACTCTTGGTT, RS, 5-GAGGCACTGGATGGAAGC,
FT, 5-CCACAAAAAGCCACAACAGGTCGCTCATCCCG-
TCAGTCATCCCTCACGGCACTCTTGGTT, RT, 5-TGTT-
GTGGCTTTTTGTGGGGTTTTCTGCACTGAAATATCG-
AGGCACTGGATGGAAGC. Primers for mCD163chim1
were: PAS, 5-GAGGGTACCATGGGTGGACACAGAATG,
PAr, 5-CTGAAGTCTTATCTTGTTGTCACAGATGATCC-
AGGACTC, PBs, 5-TCCTGGATCATCTGTGACAACAAG-
ATAAGACTTCAGGAA, PBr, 5-GAGCTCGAGTCACTGG-
GTTATAAATTC. Primers for mCD163chim2 were: PAS, 5-
GAGGGTACCATGGGTGGACACAGAATG, PAr, 5-TTT-
CTGCACTGAAATATCGAGGCACTGGATGGAAGCATC,
PBs, 5-GCTTCCATCCAGTGCCTCGATATTTCAGTGCA-
GAAAACC, PBr, 5-GAGCTCGAGTCACTGGGTTATAAA-
TTC. Primers for mCD163chim3 were: PAS, 5-GAGGGTAC-
CATGGGTGGACACAGAATG, PAr, 5-GATCCCGACTG-
CAATAAAGGTGGGGTGACCTGTGCCATG, PBs, 5-GGC-
ACAGGTCACCCCACCTTTATTGCAGTCGGGATCCTT,
PBr, 5-GAGCTCGAGTCACTGGGTTATAAATTC. Primers
for mCD163chim4 were: PAS, 5-GAGGGTACCATGGGTG-
GACACAGAATG, PAr, 5-CTGTCTTCGCTTTTTAGTCC-
ACAGGAGGAAGACAATGAG, PBs, 5-ATTGTCTTCCTC-
CTGTGGACTAAAAAGCGAAGACAGAGA, PBr, 5-GAG-
CTCGAGTCACTGGGTTATAAATTC.
In Vivo Experiments—For the experimental endotoxemia
studies (approved by the Danish Animal Welfare Committee),
C57BL/6 mice were injected intravenously with 2.5 mg/kg of
LPS (0111:B4, Sigma-Aldrich) in the tail vein. Blood sampling
was done under isoflurane anesthesia by orbital bleeding at 0,
30, 60, 120, or 240 min after injection. Serum was collected by
centrifugation (3000 g, 20 min) of coagulated blood and ana-
lyzed for TNF- and sCD163 as described. WT C57BL/6 mice
were obtained fromTaconic (Ry, Denmark). ADAM17ex/ex (26)
and Cd163/ (18) mice have been described previously. All
mice were maintained at conventional conditions with water
and food ad libitum.
Statistical Analysis—To analyze the effect of PMA stimula-
tion or amino acid mutations on shedding, Student’s t test was
performed to test for significance between means. Differences
were considered significant if p 0.05.
RESULTS
A progressive protein alignment algorithmwas used to com-
pare the juxtamembrane sequences of human CD163 and
human proTNF- (Fig. 1A); this identified a palindromic
sequence consisting of 78Arg-Ser-Ser-Ser-Arg situated next to
the ADAM17 cleavage site in proTNF- (76A2V) and a similar
palindrome, 1044Arg-Ser-Ser-Arg, in CD163. A cross-species
protein alignment revealed that the Arg-Ser-Ser-Ser-Arg
sequence is rather well conserved in the juxtamembrane region
of proTNF- (Fig. 1B), whereas the Arg-Ser-Ser-Arg sequence
is only present in human and monkey CD163 (Fig. 1C). The
Arg-Ser-(Ser)-Ser-Arg sequences both in proTNF- (all spe-
cies) and in human andmonkey CD163 are preceded by a small
hydrophobic residue, which in TNF- represents the final
N-terminal residue. A distance-based phylogenetic tree based
on the cross-species alignment of the juxtamembrane region of
CD163 (Fig. 1C) showed a high sequence identity within groups
of primates, domestic animals, and rodents.
The importance of the Arg-Ser-Ser-Arg sequence in
PMA-induced cleavage of hCD163 was analyzed by compar-
ing the PMA-induced shedding of CD163 in HEK293 cells
expressing either wild type hCD163 or the hCD163 1044RS/AA
and 1046SR/AA mutants (Fig. 2, A and C). The mutants were
expressed at the cell surface at comparable levels to wild type
hCD163. When we incubated HEK293 cells expressing
hCD163 with PMA, the level in the medium increased several-
fold to 9 g/ml (Fig. 2C). In contrast, both the constitutive
soluble CD163 release and the PMA-induced release from
HEK293 cells expressing hCD163 1044RS/AA were greatly
reduced. Release of sCD163 was also inhibited in HEK293 cells
expressing the hCD163 1046SR/AAmutant, although to a lower
extent. This indicates that the entire Arg-Ser-Ser-Arg motif is
essential for efficient cleavage, albeit the initial Arg-Ser dipep-
tide seems particularly important. Inhibition of PMA-induced
shedding is also observed when introducing the RS/AA muta-
tion in proTNF- (proTNF- 78RS/AA) (Fig. 2, B andD). Incu-
bation of HEK293 cells expressing proTNF- with PMA
resulted in highly increased TNF- levels. However, despite
similar surface expression of proTNF- 78RS/AA and wild type
proTNF-, no increase of TNF- is measured in the medium
when incubating HEK293 cells expressing proTNF- 78RS/AA
with PMA (Fig. 2D). Interestingly, introduction of the RS/AA
mutation inhibits both the constitutive and the PMA-induced
shedding in CD163, whereas only the PMA-induced shedding
is affected when the RS/AA mutation is introduced in
proTNF- (Fig. 2, B and D).
To establish whether CD163 is shed in mice, the sCD163
level in mouse serum was estimated by an ELISA specific for
ADAM17-mediated Shedding of CD163 and proTNF- in Macrophages
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mouse CD163 (Fig. 3). The concentration of sCD163 in naive
mice was 300 ng/ml, whereas no sCD163 was detected in
Cd163/ mice (Fig. 3A). To analyze the effect of LPS on
sCD163 serum concentration in mice, an experimental endo-
toxemia study was performed (Fig. 3B). Mice received an LPS
bolus (2.5 mg/kg) intravenously in the tail vein, and serum con-
centrations of both sCD163 and TNF-were monitored over a
240-min time period. As expected, a considerable increase in
the TNF- level was observed after 60 min followed by a fast
clearancewith no detectable TNF- after 240min. In contrast, no
change in serum concentration of sCD163 was observed at any of
the analyzed time points. To investigate the involvement of
ADAM17 in shedding of mouse CD163, the experimental endo-
toxemia study was repeated in hypomorphic ADAM17ex/ex mice,
which exhibit over 95% reduction in ADAM17 expression (26).
Challenging ADAM17wt/wt and ADAM17ex/ex mice with LPS
resulted in a strong release of TNF- to the circulation in
ADAM17wt/wt mice, whereas no detectable levels of TNF-
were measurable in ADAMex/ex mice (Fig. 3C), highlighting
that proinflammatory shedding of TNF- solely depends on
ADAM17 activation. Opposed to this, comparable levels of
sCD163 were detected in plasma of both ADAM17wt/wt and
ADAM17ex/ex mice after LPS challenge (Fig. 3D).
Analysis of LPS-induced shedding of CD163 and TNF-was
repeated in vitro using MBDMs. MBDMs were maturated by
M-CSF, which led to a substantial CD163 expression as verified
by image cytometric analysis (Fig. 4A). When we incubated
MBDMs with LPS, a large increase in TNF- was detected in
the culture medium, whereas no increase was observed in the
level of sCD163 (Fig. 4B).
To further validate the involvement of the juxtamembrane
region in shedding of humanCD163, juxtamembrane chimeras
were prepared and expressed in HEK293 cells (Fig. 5A). The
chimeras consisted of either mouse CD163 with the human
juxtamembrane region (mCD163hjux) or human CD163 with
the mouse juxtamembrane region (hCD163mjux). The chime-
raswere expressed at the cell surface at either comparable levels
(hCD163mjux) or lower levels (mCD163hjux) as compared
with thewild type protein (Fig. 5B , panels a and b). Fig. 5,C and
D, show an immunoblot analysis of CD163 shedding after
inductionwith various PMAconcentrations.Whenwe exposed
HEK293 cells expressing hCD163 to increasing concentrations
of PMA, a dose-dependent release of sCD163 was observed
(Fig. 5C). In contrast, only a very low and dose-independent
release of sCD163 observed when incubating HEK293 cells
expressing hCD163mjux with increasing PMA concentrations.
However, in HEK293 cells expressing either mCD163 or
mCD163hjux, only mCD163hjux-expressing cells displayed a
PMA dose-dependent release of sCD163 (Fig. 5D). Interestingly,
preincubation of the transfected cells with TIMP3, an ADAM17
inhibitor, inhibited the PMA-induced release of hCD163 and
mCD163hjux (Fig. 5, E and F) The effect of hCD163 juxtamem-
brane sequence on shedding of mouse CD163 was further inves-
tigated using chimeras (mCD163chim1–4) consisting of
mouseCD163 substitutedwith varying length of humanCD163
(Fig. 6A). PMA-induced and TIMP3-inhibited release of
sCD163 was only observed in chimeras containing the human
CD163 juxtamembrane region (Fig. 6, C and D). This also
includedmCD163chim2, which showed a lower CD163 surface
expression as compared with wild type mCD163 and mCD163
chimeras (Fig. 6, B and C).
Having established a positive effect of the humanCD163 jux-
tamembrane region on shedding of mouse CD163, the impor-
tance of the Arg-Ser-Ser-Arg sequence was analyzed by intro-
ducing this specific motif next to the conserved Thr-Gly
dipeptide in the juxtamembrane region of mouse CD163 (Fig.
7A). Introduction of the Arg-Ser-Ser-Arg sequence in mouse
CD163 did not change the surface expression of CD163 (Fig.
7B). Instead, the 4-amino acid insert induced a PMA-stimu-
lated and TIMP3-inhibited release of mouse sCD163 (Fig. 7, C
and D). When we transfected mCD163 RSSR-expressing
HEK293 cells with siRNA against ADAM17, themRNA level of
ADAM17 was reduced to 60% of controls (Fig. 7E), which
resulted in an inhibition of the PMA-induced release of sCD163
(Fig. 7F).
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FIGURE 1.Multiple sequence alignment of CD163andTNF-.A, alignment
of the human CD163 (amino acids 1030–1050) and the human proTNF-
(amino acids 57–87) juxtamembrane sequences. Identical amino acids are
marked in red. B and C, cross-species alignment of the TNF- juxtamembrane
sequence (B) and of the CD163 juxtamembrane sequence (C). The ADAM17
cleavage site in TNF- is marked in green, and the palindromic Arg-Ser-(Ser)-
Ser-Arg sequence is marked in orange. All alignments were done in CLCMain
Workbench version 6.8.1 using standard gap cost settings (gap open cost:
10.0 and gap extension cost: 1.0).
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DISCUSSION
In the present study, we have demonstrated that a palindromic
sequence (Arg-Ser-(Ser)-Ser-Arg) present in both human CD163
andTNF- is necessary for an efficientADAM17-mediated cleav-
age. Mutation of the palindromic sequence in human CD163
affected both the induced and the constitutive release of sCD163,
which corresponds with earlier findings suggesting that
ADAM17 functions as both a constitutive and an inducible
sheddase of CD163 (7). Cross-species sequence alignment of
the juxtamembrane region in CD163 revealed that species
other than primates completely lacked the Arg-Ser-(Ser)-Ser-
Arg sequence. In line with this, we show that despite the exis-
tence of sCD163 in mouse serum, the protein is not released to
the circulation via ADAM17-mediated cleavage. Importantly,
we were able to verify the importance of the Arg-Ser-Ser-Arg
sequence by enabling ADAM17-mediated shedding in mouse
CD163 using chimeras of mouse CD163 including the human
juxtamembrane sequence or the Arg-Ser-Ser-Arg sequence.
So far, more than 75 different proteins (2) have been identi-
fied as substrates for ADAM17. Despite the vast number of
proteins, no consensus sequence for ADAM17-mediated pro-
teolysis has been identified, and therefore it seems obvious that
ADAM17 may cleave in rather variant sequences. Screening of
peptide libraries has shown a prevalence of small hydrophobic
residues at the substrate P1 position, basic residues at P2, and
small aliphatic residues at P3, although with weaker selectivity
(27). Recently, it was also reported that the ADAM17 activity
relied on the secondary structure of the substrate and other
noncatalytic domains in the enzyme (28). The present findings
comply with the P1-P3 consensus rule in the sense that the
Arg-Ser-(Ser)-Ser-Arg sequence in both proTNF- andCD163
is preceded by a small hydrophobic residue (P1 position). Arg
and Ser in the tetrapeptide then represent the basic and small
aliphatic residue at P2 and P3, respectively. As such, It is pos-
sible that the a small hydrophobic residue followed by Arg-Ser-
(Ser)-Ser-Arg represents an optimized sequence for ADAM17-
mediated cleavage. However, it should be noted that exact
Arg-Ser-(Ser)-Ser-Arg motifs are absent from most proteins
known to be cleaved byADAM17, and themotif is therefore not
a prerequisite for ADAM17-mediated cleavage.
N-terminal sequencing has identified Val-Arg-Ser-Ser-Ser-
Arg as the N terminus of TNF-, whereas the precise cleavage
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FIGURE 2. PMA-induced release of sCD163 and TNF- fromHEK293 cells expressing CD163 and proTNF- RSXSRmutants. A and B, overview of CD163
and proTNF- Arg-Ser-(Ser)-Ser-Arg mutants. C and D, ELISA measurements of sCD163 (C) or TNF- (D) in media from cells stimulated with (PBS  PMA) or
without PMA (PBS). Data represent mean S.E. of three individual experiments. Asterisks denote a mean significant difference from wild type protein under
similar conditions (*, p 0.01; **, p 0.001 in Student’s t test). E and F, image cytometric analysis of CD163 (E) or TNF- expression (F) in HEK293 cells using
eithermousemAb anti-humanCD163 IgG (Mac2-158) ormousemAb anti-human TNF- IgG andATTO488-labeled rabbit pAb anti-mouse IgG. The dashed line
represents mock-transfected control, the dotted line represents cells expressing hCD163 (E) or TNF- (F), and the solid line represents cells expressing hCD163
RS/AA (E, panel a), hCD163 SR/AA (E, panel b), or TNF- RS/AA (F).
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site ofCD163 is unknown.However, the P1-P3 consensus rule
and the present data including the knock-in data in mouse
CD163 indicate that cleavage may occur between Thr1042 and
Gly1043. (Fig. 8). However, becauseCD163 is a type I transmem-
brane protein, which is cleaved in the C terminus, the 1043Gly-
Arg-Ser-Ser-Arg motif will not, as in the case of proTNF-,
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represent the N terminus of the released soluble product.
Instead, this sequence will constitute the N-terminal end of the
CD163 receptor stub in the membrane.
ProTNF- is a type II transmembrane protein, whereas
CD163 is a type I transmembrane protein, and as such, they
have opposite orientation. The identification of a similar palin-
FIGURE 5.PMA-induced release of CD163 inHEK293 cells expressing juxtamembrane chimeras of CD163.A, domain structure of CD163 juxtamembrane
chimeras. The human CD163 sequence is shown in blue, and the mouse CD163 sequence is shown in red. B, image cytometric analysis of CD163 surface
expression using mouse mAb anti-human CD163 IgG (Mac2-158) and goat pAb anti-mouse ATTO488 (panel a) or rabbit pAb anti-mouse CD163-ATTO488
(panel b). The dashed line represents mock-transfected control, the dotted line represents cells expressing hCD163 (panel a) or mCD163 (panel b), and the solid
line represents cells expressing hCD163mjux (panel a) or mCD163hjux (panel b). C and D, Western blot analysis of PMA-induced release of sCD163 from
transfected HEK293 cells using a PMA gradient. Immunoreactive bands were visualized using either mouse mAb anti-human CD163 (Mac2-158) and HRP-
conjugated goat anti-mouse IgG (C) or rabbit pAb anti-mouse CD163 and HRP-conjugated goat anti-rabbit IgG (D). Band intensities were estimated using the
MultiGauge software (Fujifilm Europe), and relative shedding was calculated and plotted against the PMA concentration. Shedding is relative to the band
intensity of released sCD163 from HEK293 cells expressing either hCD163 (C) or mCD163 (D) incubated with 105 ng/ml PMA. Data represent mean S.E. of
three individual experiments. E and F, Western blot analysis of sCD163 release from transfected HEK293 cells incubated with PMA and TIMP3 inhibitor.
Immunoreactive bands were visualized using either mouse mAb anti-human CD163 (Mac2-158) and HRP-conjugated goat anti-mouse IgG (E) or rabbit pAb
anti-mouse CD163 and HRP-conjugated goat anti-rabbit IgG (F).
FIGURE 6. PMA-induced release of CD163 in HEK293 cells expressing mouse CD163 substituted with varying parts of human CD163. A, domain
structure of CD163 chimeras. The human CD163 sequence is shown in blue, and the human SRCR domains are in light orange. The mouse CD163 sequence is
displayed in red, and the mouse SRCR domains are displayed in yellow. B, image cytometric analysis of CD163 expression in HEK293 cells using rabbit pAb
anti-mouse CD163-ATTO488. The dashed line represents mock-transfected control, the dotted line represents cells expressing mCD163, and the solid line
represents cells expressingmCD163chim1 (panel a),mCD163chim2 (panel b),mCD163chim3 (panel c), ormCD163chim4 (panel d).C, relative release of sCD163
fromHEK293cells expressinghuman/mouseCD163chimeras. Shedding is relative to releaseof sCD163 fromPMA-incubatedHEK293cells expressingmCD163.
Levels of sCD163 in the supernatant of unstimulated (PBS) and PMA-stimulated cells (PBS PMA) was measured by immunoblot analysis. Immunoreactive
bands were visualized by rabbit pAb anti-mouse CD163 and HRP-conjugated goat anti-rabbit IgG. Band intensities were subsequently quantified using the
MultiGauge software (Fujifilm Europe). An asterisk denotes a mean significant difference from untreated control (p 0.0001). Data represent mean S.E. of
three individual experiments. D, Western blot analysis of sCD163 release from CD163-transfected HEK293 cells incubated with PMA and TIMP3 inhibitor.
Immunoreactive bands were visualized using rabbit pAb anti-mouse CD163 and HRP-conjugated goat anti-rabbit IgG.
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dromic sequence important forADAM17-mediated cleavage in
opposite oriented substrates could suggest a parallel to palin-
dromic sequences known from DNA restriction enzymes.
However, palindromic peptide sequences are not identical
structures in both directions due to the unidirectional orienta-
tion of the carboxyl and amino groups involved in the peptide
bonds. Consequently, both proTNF- andCD163 have to pres-
ent the Arg-Ser-(Ser)-Ser-Arg sequence to the membrane-as-
sociated ADAM17 in the same orientation. Flexibility of the
juxtamembrane regions in CD163 or proTNF-may allow the
right orientation for recognition by ADAM17. Alternatively,
high flexibility of the extracellular domain of ADAM17 could
also allow recognition of the motif in either orientation.
In the present study, we have shown thatmouse CD163 lacks
the ability to undergoADAM17-dependent shedding, although
sCD163 is easily detectable in mouse serum. So far, it is not
known whether mouse sCD163 is released via regulated prote-
olysis or merely as a byproduct of macrophage turnover.
Recently, it was shown that another human ADAM17 sub-
strate, the interleukin-6 receptor, was not shed by this enzyme
in mice (29). Instead, the substrate was shed by the closely
related ADAM10, which only had minimal activity toward the
substrate in humans. One could also speculate that CD163 in
mouse serum is an uncleaved receptor present in macrophage-
released exosomes, as has been shown for the structurally
related protein CD163-L1 in humans (30). Given the relatively
FIGURE 7.PMAefficiently induces anADAM17-dependent releaseof CD163 inHEK293 cells expressingmouseCD163 containing theArg-Ser-Ser-Arg
sequence. A, sequence ofmCD163 andmCD163 RSSRmutant. B, image cytometric analysis of CD163 expression in HEK293 cells using rabbit pAb anti-mouse
CD163-ATTO488. The dashed line represents mock-transfected control, the dotted line represents cells expressing mCD163, and the solid line represents cells
expressingmCD163-RSSR. C, relative release of sCD163 fromHEK293 cells expressing themouse CD163 ormouse CD163 RSSRmutant. Shedding is relative to
release of sCD163 from PMA-incubated HEK293 cells expressing mCD163. Levels of sCD163 in supernatant of unstimulated (PBS) and PMA-stimulated cells
(PBS PMA) were measured by immunoblot analysis. Immunoreactive bands were visualized using rabbit pAb anti-mouse CD163 and HRP-conjugated goat
anti-rabbit IgG. The intensities of the immunoreactive bands were subsequently quantified using the MultiGauge software (Fujifilm Europe). An asterisk
denotes amean significant difference fromwild type protein under similar conditions (p 0.05). Data represent mean S.E. of three individual experiments.
D, Western blot analysis of sCD163 release from CD163-transfected HEK293 cells incubated with PMA and TIMP3 inhibitor. Immunoreactive bands were
visualized using rabbit pAb anti-mouse CD163 and HRP-conjugated goat anti-rabbit IgG. E, semiquantitative RT-PCR analysis of gene-specific siRNA silencing
of ADAM17 in mouse CD163 RSSR-expressing HEK293 cells, which were either mock-transfected or transfected with siRNA against ADAM17 or scrambled
siRNA. Cells were harvested 48 h after transfection and subjected to RT-PCR analysis using -actin as control. F, Western blot analysis of sCD163 release from
siRNA-transfected HEK293 cells expressing the mouse CD163 RSSR mutant. Immunoreactive bands were visualized using rabbit pAb anti-mouse CD163 and
HRP-conjugated goat anti-rabbit IgG.
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high level of sCD163 inmouse and human plasma, it is possible
that a common basal level of exosome-associated CD163 exists
in both species and that humans under inflammatory condi-
tions are able to increase the concentration of the receptor in
plasma by ADAM17-dependent release of sCD163.
Interestingly, the striking difference in human and mouse
CD163 in terms of ADAM17-mediated cleavage parallels a
number of other differences in the function of primate hap-
toglobins versus the haptoglobins in non-primates. One
example is the primate-specific defense mechanism against
trypanosome parasites. Here, the primate-specific haptoglobin
gene duplication product, haptoglobin-related protein, binds
together with another primate-specific protein, apolipopro-
tein-L1, to exert a trypanolytic function (15). Another example
is our recent finding that human haptoglobin upon complex
formation with hemoglobin has a much higher affinity for
CD163 than mouse haptoglobin in complex with hemoglobin
(18). In return, mouse free hemoglobin binds with higher affin-
ity to CD163 as compared with human hemoglobin. Appar-
ently, the difference in affinity between haptoglobin-hemoglo-
bin complexes in the two species relies on a primate-specific
presence of two basic residues in a haptoglobin loop that
interacts withCD163when haptoglobin is complexed to hemo-
globin (31). A third example, the plasma concentration of hap-
toglobin, is generally much higher in primates versus in non-
primates (32, 33).
The serious threat of trypanosome parasites causing sleeping
sicknessmost likelymay have driven the evolution of resistance
toward certain types of trypanosome parasites by means of pri-
mate-specific haptoglobin-related protein and apolipopro-
tein-L. It is tempting to speculate that other infectious diseases
such as malaria or other hemolytic infections may also have
caused an evolutionary pressure leading to development of
additional protection by haptoglobin. However, the increased
protection obtained by higher concentrations of haptoglobin
and a faster CD163-mediated clearance of haptoglobin-hemo-
globin complexes may lead to an inexpedient overdamping of
the inflammatory response induced by anti-inflammatory
hememetabolites. Hence, anADAM17-dependentmechanism
to down-regulate CD163 expression in primates may have
evolved to tune the system and thereby achieve the right bal-
ance between protection from hemolysis and overdamping of
the proinflammatory response.
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